Novakand Pharma AB (publ) (STO:NOVKAN)

Novakand Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	15	133	370	169	344	712
Market Cap Growth	-88.39%	-64.21%	119.29%	-50.92%	-51.68%	637.89%
Enterprise Value	-7	75	312	101	226	665
Last Close Price	0.13	1.09	4.44	2.08	5.99	15.75
PS Ratio	-	-	-	-	-	7913.47
PB Ratio	0.77	2.13	7.77	1.58	2.81	9.85
P/TBV Ratio	0.77	2.99	12.49	1.97	3.39	13.89
EV/Sales Ratio	-	-	-	-	-	7393.00
Debt / Equity Ratio	-	-	-	-	0.01	0.02
Asset Turnover	-	-	-	-	-	0.00
Quick Ratio	7.24	10.39	2.61	6.94	10.72	5.70
Current Ratio	7.34	10.61	2.65	7.20	10.72	6.22
Return on Equity (ROE)	-112.86%	-81.05%	-83.96%	-45.75%	-46.90%	-90.30%
Return on Assets (ROA)	-42.81%	-43.53%	-44.32%	-25.91%	-27.11%	-43.76%
Return on Invested Capital (ROIC)	-46.88%	-52.47%	-53.43%	-28.63%	-29.84%	-51.14%
Return on Capital Employed (ROCE)	-172.20%	-74.10%	-138.60%	-49.30%	-38.20%	-60.90%
Earnings Yield	-337.22%	-33.62%	-17.52%	-31.07%	-13.28%	-5.69%
FCF Yield	-	-44.15%	-15.03%	-28.16%	-12.82%	-5.47%
Buyback Yield / Dilution	-17.04%	-44.85%	-36.90%	-3.91%	-54.18%	-82.68%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.